CSTL
CASTLE BIOSCIENCES INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$35.34
−3.92%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.38
- Revenue estimate
- $92.1M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.41
- Revenue actual
- $103.5M
- Revenue estimate
- $86.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +264.6%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $42
- PT range
- $40 – $44
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.41 | -$0.07 | Beat 82.80% | $103.5M |
| May 6, 2026 | -$0.49 | -$0.49 | In line | $84.2M |
| Feb 27, 2025 | -$0.04 | $0.32 | Beat 900.00% | $86.3M |
| May 2, 2024 | -$0.37 | -$0.09 | Beat 75.68% | $73.0M |
| Feb 28, 2024 | -$0.84 | -$0.10 | Beat 88.10% | $66.1M |
| Nov 2, 2023 | -$0.92 | -$0.26 | Beat 71.74% | $61.5M |
| Aug 2, 2023 | -$1.01 | -$0.70 | Beat 30.69% | $50.1M |
| May 3, 2023 | -$0.80 | -$1.10 | Miss -37.50% | $42.0M |
| Feb 28, 2023 | -$0.91 | -$0.78 | Beat 14.29% | $38.3M |
| Nov 2, 2022 | -$0.70 | -$0.77 | Miss -10.00% | $37.0M |
| Feb 28, 2022 | -$0.43 | -$0.25 | Beat 41.86% | $25.0M |
| Mar 8, 2021 | -$0.11 | -$0.16 | Miss -45.45% | $17.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026